Ebola Virus Infectivity: Extremely Low Infectious Dose
Ebolaviruses are among the most infectious known pathogens. Experimental and epidemiological evidence indicates:
- Infectious dose (ID50): Estimated at 1–10 viral particles via parenteral or mucosal exposure in nonhuman primates. Human data consistent with extremely low dose.
- Comparison: Influenza ID50 ~100–1,000 particles; SARS-CoV-2 estimated ~100–1,000; Norovirus ~18 particles.
Why So Infectious?
- Broad cell tropism: Infects macrophages, dendritic cells, endothelial cells, hepatocytes, fibroblasts via multiple receptors (NPC1, TIM-1, integrins).
- Rapid replication: High viral loads (107–109 RNA copies/mL blood) within days.
- Immune evasion: VP35 and VP24 proteins block interferon signaling, delaying innate/adaptive responses.
- Cell-to-cell spread: Syncytia formation and virological synapses enhance dissemination.
- Environmental stability: Persists days in body fluids on surfaces at room temperature; longer in cold/wet conditions.
Transmission Implications
- Minute fluid exposures (needlestick, splash to mucosa) can transmit.
- High viral loads in late-stage patients → extreme infectiousness of bodies/fluids.
- Explains nosocomial amplification without rigorous IPC.
- Does not imply airborne transmission—still requires direct contact with infectious material.
This extreme infectivity underscores the need for maximum barrier precautions and zero-tolerance for protocol breaches in clinical and laboratory settings.
Viral Infections - Related Articles
- Poliomyelitis (Polio): Viral Infection of Spinal Cord Gray Matter
- How Smallpox Spreads: Transmission Routes Explained
- Understanding Flu Shot Side Effects: Symptoms and What to Expect
- Protect Yourself: Understanding and Preventing Stomach Bugs
- P. falciparum Malaria: Three-Day Cycle, Symptoms, and Treatment
- How Viruses and Bacteria Damage Cells: Mechanisms of Pathogen Injury
- Viral Infections and Blood Sugar: Understanding the Link
